Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma : half of patients respond to a four-dose treatment program

• MCLAUGHLIN P

収録刊行物

• J Clin Oncol

  J Clin Oncol 16 2825-2833, 1998

詳細情報

• CRID: 1574231875098427136
• NII論文ID: 10018924955
• データソース種別:
  • CiNii Articles